Biological Psychiatry
Volume 66, Issue 10 , Pages 958-963 , 15 November 2009

Phthalates Exposure and Attention-Deficit/Hyperactivity Disorder in School-Age Children

  • Bung-Nyun Kim

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Soo-Churl Cho

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Yeni Kim

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Min-Sup Shin

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Hee-Jeong Yoo

      Affiliations

    • Department of Psychiatry, Seoul National University Bundang Hospital, Seong-nam, Republic of Korea
    • ,
  • Jae-Won Kim

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Young Hee Yang

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Hyo-Won Kim

      Affiliations

    • Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Soo-Young Bhang

      Affiliations

    • Department of Psychiatry, Ulsan University Hospital, Ulsan, Republic of Korea
    • ,
  • Yun-Chul Hong

      Affiliations

    • Department of Preventive Medicine, Seoul National University College of Medicine and Institute of Environmental Medicine, SNUMRC, Seoul, Republic of Korea
    • Corresponding Author InformationAddress correspondence to Yun-Chul Hong, M.D., Ph.D., Department of Preventive Medicine, Seoul National University College of Medicine and Institute of Environmental Medicine, SNUMRC, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Republic of Korea

Received 23 February 2009 ,Revised 16 July 2009 ,Accepted 22 July 2009.

References 

  1. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?. Risk Anal. 2006;26:803–824
  2. Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. NTP Center for the Evaluation of Risks to Human Reproduction: Phthalates expert panel report on the reproductive and developmental toxicity of di-n-hexyl phthalate. Reprod Toxicol. 2002;16:709–719
  3. Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. NTP Center for the Evaluation of Risks to Human Reproduction: Phthalates expert panel report on the reproductive and developmental toxicity of di-n-octyl phthalate. Reprod Toxicol. 2002;16:721–734
  4. Tabacova S, Balabaeva L, Little RE. Maternal exposure to exogenous nitrogen compounds and complications of pregnancy. Arch Environ Health. 1997;52:341–347
  5. Gladen BC, Tabacova S, Baird DD, Little RE, Balabaeva L. Variability of lipid hydroperoxides in pregnant and nonpregnant women. Reprod Toxicol. 1999;13:41–44
  6. Masuo Y, Morita M, Oka S, Ishido M. Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: A study inspired by the physiological roles of PACAP in the brain. Regul Pept. 2004;15:225–234
  7. Stewart PW, Reihman J, Lonky EI, Darvill TJ, Pagano J. Cognitive development in preschool children prenatally exposed to PCBs and MeHg. Neurotoxicol Teratol. 2003;25:11–22
  8. Jacobson JL, Jacobson SW. Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr. 2003;143:780–788
  9. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Publications; 1998;
  10. So YK, Noh JS, Kim YS, Ko SG, Koh YJ. The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc. 2002;41:283–289
  11. Greenberg LM, Waldman ID. Developmental normative data on the test of variables of attention (TOVA). J Child Psychol Psychiatry. 1993;34:1019–1030
  12. Shin MS, Cho S, Chun SY, Hong KE. A study of the development and standardization of ADHD diagnostic system. Korean Journal of Child and Adolescent Psychiatry. 2000;11:91–99
  13. Park KS, Yoon JY, Park HJ, Park HJ, Kwon KU. Development of KEDI-WISC, Individual Intelligence Test for Korean Children. Seoul: Korean Educational Development Institute; 1996;
  14. Kaufman AS. A four test short form of the WISC-R. Comtemporary Educ Psychol. 1976;1:180–196
  15. Ishido M, Masuo Y, Sayato-Suzuki J, Oka S, Niki E, Morita M. Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurochem. 2004;91:69–76
  16. Masuo Y, Ishido M, Morita M, Oka S. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. Neural Plast. 2004;11:59–76
  17. Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect. 2000;108:511–533
  18. Adams J, Barone S, LaMantia A, Philen R, Rice DC, Spear L, et al. Workshop to identify critical windows of exposure for children's health: Neurobehavioral work group summary. Environ Health Perspect. 2000;108:535–544
  19. Vorhees CV. Developmental neurotoxicity induced by therapeutic and illicit drugs. Environ Health Perspect. 1994;102:145–153
  20. Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect. 2000;108:511–533
  21. Mendola P, Selevan SG, Gutter S, Rice D. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev. 2002;8:188–197
  22. Miller MW. Migration of cortical neurons is altered by gestational exposure to ethanol. Alcohol Clin Exp Res. 1993;17:304–314
  23. Levitt P. Prenatal effects of drugs of abuse on brain development. Drug Alcohol Depend. 1998;51:109–125
  24. Petit TL, Alfano DP, LeBoutillier JC. Early lead exposure and the hippocampus: A review and recent advances. Neurotoxicology. 1983;4:79–94
  25. White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 2007;225:1–27
  26. Lidsky TI, Schneider JS. Lead neurotoxicity in children: Basic mechanisms and clinical correlates. Brain. 2003;126:5–19
  27. Shaywitz BA, Yager RD, Klopper JH. Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction. Science. 1976;191:305–308
  28. Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1263–1272
  29. Adriani W, Boyer F, Gioiosa L, Macrì S, Dreyer JL, Laviola G. Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens. Neuroscience. 2009;159:47–58
  30. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999;354:2132–2133
  31. Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging. 2003;30:306–311
  32. Corton JC, Lapinskas PJ. Peroxisome proliferator-activated receptors: Mediators of phthalate ester-induced effects in the male reproductive tract?. Toxicol Sci. 2005;83:4–17
  33. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56:993–998
  34. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry. 2001;6:425–428
  35. Barr CL, Wigg KG, Bloom S, Schachar R, Tannock R, Roberts W, et al. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet. 2000;96:262–267
  36. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, et al. Association of the dopamine receptor D4(DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder: A family-based approach. Mol Psychiatry. 1998;3:370–372
  37. Kim JW, Kim BN, Cho SC. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: A case-control association study in a Korean sample. J Psychiatr Res. 2006;40:730–737
  38. Yang JW, Jang WS, Hong SD, Ji YI, Kim DH, Park J, et al. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: Evidence of association with the -521 C/T SNP. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:243–248
  39. Cheon KA, Kim BN, Cho SC. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsychopharmacology. 2007;32:1377–1383
  40. Kim YN, Shin MS, Kim JW, Yoo HJ, Cho SC, Kim BN. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD. Hum Psychopharmacol Clin Exp. 2009;24:95–102
  41. Bellinger DC. Late neurodevelopmental effects of early exposures to chemical contaminants: Reducing uncertainty in epidemiological studies. Basic Clin Pharmacol Toxicol. 2008;102:237–244
  42. Yang YH, Kim JW, Kim YN, Cho SC, Kim BN. Screening of attention deficit hyperactivity disorder in Seoul. J Korean Neuropsychatr Assoc. 2008;47:292–298
  43. Koch HM, Bolt HM, Angerer J. Di-2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol. 2004;78:123–130
  44. Fennell TR, Krol WL, Sumner SC, Snyder RW. Pharmacokinetics of dibutylphthalate in pregnant rats. Toxicol Sci. 2004;82:407–418

PII: S0006-3223(09)00952-4

doi: 10.1016/j.biopsych.2009.07.034

Biological Psychiatry
Volume 66, Issue 10 , Pages 958-963 , 15 November 2009

Article Tools

* Image Usage & Resolution